Trade and investment liberalization and Asia’s noncommunicable disease epidemic: a synthesis of data and existing literature

Abstract

Trade liberalization is a significant driver of the NCD epidemic in Asia. Increased participation in trade agreements requires countries to strengthen regulatory capacity to ensure adequate protections for public health. How best to achieve this through multilateral, regional and unilateral actions is a pressing question for ongoing research.